| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 10/05/2005 | CN1221551C Aminotriazolopyridine derivatives as adenosine receptor ligands |
| 10/04/2005 | US6951851 Substituted pyrazoles |
| 09/29/2005 | WO2005090351A1 Method for preparing compounds comprising cucurbituril groups |
| 09/29/2005 | WO2005090341A1 Azabicyclooctan-3-one derivatives and use thereof |
| 09/29/2005 | WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative |
| 09/29/2005 | US20050215584 Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease |
| 09/29/2005 | CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative |
| 09/29/2005 | CA2556857A1 Method for preparing compounds comprising cucurbituril groups |
| 09/28/2005 | EP1578743A2 Antibacterial agents |
| 09/28/2005 | EP1361880B1 6-substituted pyrido-pyrimidines |
| 09/28/2005 | EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 09/27/2005 | US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 09/27/2005 | US6949540 Substituted pyrazoles |
| 09/22/2005 | WO2005087846A1 Supramolecular complex of pyridylnaphthalenediimide with zinc porphyrin dendrimer having multiplicity of artificial photosynthetic reaction center |
| 09/22/2005 | US20050209456 Vascular endothelial growth factor; tyrosine kinase inhibitor; angiogenesis inhibitor; anticancer agents |
| 09/22/2005 | US20050209253 Corticotropin releasing factor (CRF) receptor antagonists; nervous system disorders, ischemia, gastrointestinal disorders, hypertension, eating disorders, sleep disorders; e.g. 2-(1-[7-(2,6-dibromo-4-trifluoromethyl-phenyl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-piperidin-2-yl)-ethanol |
| 09/22/2005 | US20050209210 Having activity against both rifampin and ciprofloxacin-resistant microorganisms |
| 09/22/2005 | US20050205895 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device |
| 09/21/2005 | EP1577301A1 Diamine derivatives |
| 09/21/2005 | EP1575960A2 1,4-diazabicyclo 3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof |
| 09/21/2005 | CN1671716A Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/21/2005 | CN1671711A Calcitonin gene related peptide receptor antagonists |
| 09/20/2005 | US6946472 Polycyclic compounds exhibiting anti-tumor activities |
| 09/20/2005 | US6946455 Interstrand crosslinking agents for DNA and compounds therefor |
| 09/15/2005 | WO2005085260A1 Pyrrolobenzodiazepines |
| 09/15/2005 | WO2005085259A2 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 09/15/2005 | WO2005085251A1 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines |
| 09/15/2005 | WO2005085250A1 C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases |
| 09/15/2005 | WO2005085228A1 Cycloalkanopyridine derivative |
| 09/15/2005 | US20050203118 Rheumatic diseases; antiarthritic agents; multiple sclerosis; antidiabetic agents; asthma therapy; skin disorders |
| 09/15/2005 | US20050203065 Use of A2b adenosine receptor antagonists such as 3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid (BG 9928) |
| 09/15/2005 | CA2558274A1 Cycloalkanopyridine derivative |
| 09/14/2005 | EP1572700A1 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 09/14/2005 | EP1572693A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
| 09/14/2005 | EP1572682A2 Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
| 09/14/2005 | EP1529048A4 Methods for the synthesis of substituted purines |
| 09/14/2005 | CN1669162A Electrode-active material and electrodes made by using the same, and cells equipped with the electrodes |
| 09/14/2005 | CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 09/14/2005 | CN1668620A 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/14/2005 | CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives |
| 09/14/2005 | CN1668615A Novel benzimidazole derivatives |
| 09/14/2005 | CN1218950C Production method of catharanthine |
| 09/13/2005 | US6943253 6-phenylpyrrolopyrimidinedione derivatives |
| 09/13/2005 | US6943199 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 09/13/2005 | US6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones |
| 09/13/2005 | CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them |
| 09/09/2005 | WO2005082910A1 Process for isolation of ergot alkaloids from ergot |
| 09/09/2005 | WO2005082887A1 Pyrimidine derivative |
| 09/09/2005 | WO2005082852A1 Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2556776A1 Process for isolation of ergot alkaloids from ergot |
| 09/08/2005 | US20050197333 Rifamycin analogs and uses thereof |
| 09/07/2005 | EP1569936A1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 09/07/2005 | EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 09/07/2005 | EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 09/07/2005 | EP1401839B1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene |
| 09/07/2005 | CN1666577A Electronic devices made with electron transport and/or anti-quenching layers |
| 09/07/2005 | CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/01/2005 | WO2005080402A1 Thienopyroles as antagonists of gnrh |
| 09/01/2005 | WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
| 09/01/2005 | WO2005070133A3 2,6-disubstituted piperidines as modulators of chemokine receptor activity |
| 09/01/2005 | WO2005063744A3 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
| 09/01/2005 | US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses |
| 09/01/2005 | US20050192253 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 08/31/2005 | EP1567527A1 Condensed pyrazolo derivatives |
| 08/31/2005 | EP1567520A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 08/31/2005 | EP1382608B1 Sulfate of cephem compound |
| 08/31/2005 | CN1662537A Pyrazolo (1, 5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same |
| 08/31/2005 | CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 08/31/2005 | CN1660853A Indolecarboxylic ester trimer and electrochemical cell using the same |
| 08/30/2005 | US6936723 Anticancer activity and V-ATPase inhibition; improved stability over natural benzolactones |
| 08/30/2005 | US6936603 Treating autoimmune diseases mediated by cathepsin S |
| 08/25/2005 | WO2005077984A1 Process for producing organic compound and antibody for use therein |
| 08/25/2005 | WO2005077955A1 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 08/25/2005 | WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/25/2005 | US20050185247 Indolecarboxylic ester trimer and electrochemical cell using the same |
| 08/25/2005 | CA2555884A1 Amino-substituted tricyclic derivatives and methods of use |
| 08/25/2005 | CA2549954A1 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 08/24/2005 | EP1360185B1 Carboline derivatives |
| 08/24/2005 | EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | CN1659166A 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 08/24/2005 | CN1659165A Quinolinone derivatives |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658724A Luminescent element material and luminescent element comprising the same |
| 08/18/2005 | WO2005075479A1 Dimeric azacyclic compounds and their use |
| 08/18/2005 | WO2005055943A3 Vinorelbine derivatives |
| 08/18/2005 | WO2005054236B1 Substituted quinolines for the treatment of cancer |
| 08/18/2005 | US20050182072 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 08/18/2005 | US20050182062 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof |
| 08/18/2005 | US20050182058 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents |
| 08/18/2005 | US20050179013 Hyperpolarizable organic chromophores |
| 08/17/2005 | EP1562959A2 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| 08/17/2005 | EP1562955A1 Quinazoline derivatives as src tyrosine kinase inhibitors |
| 08/17/2005 | EP1562949A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 08/17/2005 | EP1562946A1 Novel xanthine derivatives, the production and the use thereof in the form of drugs |
| 08/17/2005 | EP1562944A1 Pyrazoloquinolines with immunomodulating activity |